Head of Clinical Operations for Epic Bio, where he oversees all Clinical Operations activities in support of Epic’s clinical trials. He has a background in patient care setting, as well as research-focused clinics on the ground level of clinical trials before moving into research management. For the last 20+ years he has led cross-functional teams carrying out global multicenter trials – in all phases of drug development – and multiple therapeutics areas including Neuro, Oncology and Immunology. He has experience with both large and small molecules therapeutics as well as gene therapies and now epigenetic therapies with Epic Bio.
For the last decade his focus has been on building capabilities for startup Biotechs to tackle rare and ultra-rare diseases and has launched first-in-human therapeutics for companies like Genentech, Audentes, Cytokinetics, Jasper Therapeutics and Kezar Life Sciences.
Ken has an International Executive MBA in Business and Finance from the International School of Management (ISM) in Paris, France.